Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Domestic and Foreign Components of Income (Loss) |
The domestic and foreign components of income (loss) from continuing operations are as follows: | | | | | | | | | | | | | Year Ended December 31, | | 2022 | | 2021 | | Domestic | $ | (131,237,000) | | | $ | (78,356,000) | | | Foreign | 525,000 | | | 204,000 | | | Loss before provision for income taxes | $ | (130,712,000) | | | $ | (78,152,000) | |
|
| Schedule of Provision for Domestic and Foreign Income Taxes |
The provision for domestic and foreign income taxes is as follows: | | | | | | | | | | | | | Year Ended December 31, | | 2022 | | 2021 | | Current: | | | | | Federal | $ | — | | | $ | — | | | Foreign | 123,000 | | | 39,000 | | | State and local | 1,000 | | | 21,000 | | | Total current income tax provision (benefit) | $ | 124,000 | | | $ | 60,000 | | | Deferred: | | | | | Federal | $ | (277,000) | | | $ | (4,055,000) | | | Foreign | — | | | — | | | State and local | 2,037,000 | | | (1,722,000) | | | Total deferred income tax provision (benefit) | 1,760,000 | | | (5,777,000) | | | Income tax provision (benefit) | $ | 1,884,000 | | | $ | (5,717,000) | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
Reconciliations of the income tax computed at the federal statutory tax rate to the expense for income taxes are as follows: | | | | | | | | | | | | | Year Ended December 31, | | 2022 | | 2021 | | Income taxes at statutory rate | $ | (27,447,000) | | | $ | (16,413,000) | | | State income taxes, net of federal benefits | (1,321,000) | | | (2,030,000) | | | Change in valuation allowance | 27,342,000 | | | 12,879,000 | | | Stock-based compensation | 1,345,000 | | | 581,000 | | | Section 162(m) | 2,447,000 | | | 966,000 | | | Other permanent differences | 434,000 | | | 149,000 | | | Research credits | (1,733,000) | | | (938,000) | | | Other | 817,000 | | | (911,000) | | | Income tax expense (benefit) | $ | 1,884,000 | | | $ | (5,717,000) | |
|
| Schedule of Deferred Tax Assets |
Significant components of the Company’s deferred tax assets at December 31, 2022 and 2021 are as follows: | | | | | | | | | | | | | December 31, | | 2022 | | 2021 | | Deferred tax assets: | | | | | Net operating loss carryforwards | $ | 109,612,000 | | | $ | 81,399,000 | | | Research and development credits | 9,816,000 | | | 6,911,000 | | | Stock-based compensation | 1,639,000 | | | 849,000 | | | ASC 842 - lease liability | 2,599,000 | | | 2,517,000 | | | UNICAP | 1,049,000 | | | 481,000 | | | Other | 1,944,000 | | | 976,000 | | | Total gross | 126,659,000 | | | 93,133,000 | | | Deferred tax liabilities: | | | | | Amortization | (2,202,000) | | | (7,478,000) | | | ASC 842 - ROU asset | (2,441,000) | | | (2,504,000) | | | Less: valuation allowance | (122,016,000) | | | (83,151,000) | | | Deferred tax assets, net of valuation allowance | $ | — | | | $ | — | |
|
| Schedule of Unrecognized Tax Benefits |
Reconciliations of the beginning and ending amount of unrecognized tax benefits, excluding interest and penalties, are as follows: | | | | | | | | | | | | | December 31, | | 2022 | | 2021 | | Balance at beginning of the year | $ | 5,119,000 | | | $ | 4,201,000 | | | Additions/(reductions) for tax positions - prior year | 903,000 | | | 231,000 | | | Increase related to current year positions | 1,259,000 | | | 687,000 | | | Balance at the end of the year | $ | 7,281,000 | | | $ | 5,119,000 | |
|